Chief Executive Stephane Bancel says Moderna will work with the Trump administration. Moderna stock rose in midday trades.
Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA stock a buy?
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...
Moderna, maker of one of the most widely used coronavirus vaccines, disclosed that it gave its CEO $1 million for security in 2023 “in response to a heightened threat environment.” To survey ...
Our team successfully filed three Biologics License Applications in the final months of the year and reduced our costs by 27 percent compared to 2023,” said Stephane Bancel, CEO of Moderna (MRNA).
After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter Inventory write-downs and manufacturing charges are nothing new for Moderna, which has struggled ...